Common Stock, Shares, Outstanding of Acrivon Therapeutics, Inc. from 31 Dec 2021 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Acrivon Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2021 to 30 Sep 2025.
  • Acrivon Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 31,549,770, a 1.3% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Acrivon Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 31,549,770 +418,878 +1.3% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 31,449,744 +483,489 +1.6% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 31,352,067 +8,714,528 +38% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 31,231,264 +8,708,620 +39% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 31,130,892 +9,026,423 +41% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 30,966,255 +8,897,595 +40% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 22,637,539 +716,905 +3.3% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 22,522,644 +602,242 +2.7% 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 22,104,469 +20,309,869 +1132% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 22,068,660 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 21,920,634 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 21,920,402 +20,150,841 +1139% 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 1,794,600 30 Sep 2022 10-Q 15 Dec 2022 2022 Q3
Q4 2021 1,769,561 31 Dec 2021 10-K 28 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.